ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,638Medicare Part D Prescriptions Filled, Including Refills

Rank: 103 out of 1942

$438K Total Retail Price of All Prescriptions

Rank: 166 out of 1942

407 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 407 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 407 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 7,850 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 629 514 1 1
HYDROCODONE-ACETAMINOPHEN 355 266 S3 2 12
LISINOPRIL 348 306 3 2
OMEPRAZOLE 316 242 4 4
CITALOPRAM HBR 276 246 5 15
METOPROLOL TARTRATE 235 218 6 9
LEVOTHYROXINE SODIUM 224 184 7 3
AMLODIPINE BESYLATE 197 186 8 6
ZOLPIDEM TARTRATE 172 112 9 25
METOPROLOL SUCCINATE 171 129 10 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 165 131 11 22
BISOPROLOL FUMARATE 158 136 12 249
WARFARIN SODIUM 154 147 13 11
METFORMIN HCL ER 153 82 14 46
LANTUS 138 126 15 49
MIRTAZAPINE 135 124 16 38
POTASSIUM CHLORIDE 129 112 17 17
FUROSEMIDE 126 121 18 5
PREDNISONE 115 105 19 27
ASPIRIN EC 111 111 20 92
DONEPEZIL HCL 110 110 21 30
TAMSULOSIN HCL 106 101 22 29
TRIAMTERENE-HCTZ 105 62 23 36
TRAZODONE HCL 102 88 24 24
LOSARTAN POTASSIUM 101 90 25 18
GLIMEPIRIDE 97 65 26 53
MAPAP 96 96 27 104
JANUVIA 94 46 28 85
METFORMIN HCL 92 78 29 10
FLUTICASONE PROPIONATE 87 87 30 37
FENTANYL 85 68 S2 31 47
GABAPENTIN 83 56 32 16
DOCUSATE SODIUM 81 81 33 291
ATORVASTATIN CALCIUM 81 48 33 14
POLYETHYLENE GLYCOL 3350 79 60 35 28
CALCIUM WITH VITAMIN D 79 79 35 175
MULTIVITAMINS 77 77 37 260
TRAMADOL HCL 71 69 38 19
ALLOPURINOL 69 62 39 26
PRAVASTATIN SODIUM 65 57 40 23
OXYBUTYNIN CHLORIDE ER 64 64 41 118
FENOFIBRATE 63 28 42 82
CRESTOR 62 34 43 34
SPIRONOLACTONE-HCTZ 61 52 44 265
OLANZAPINE 58 58 45 94
FINASTERIDE 57 57 46 86
TRIAMCINOLONE ACETONIDE 53 36 47 71
PROAIR HFA 53 33 47 41
ALENDRONATE SODIUM 51 50 49 21
CHLORTHALIDONE 50 48 50 76
ZOSTAVAX 50 48 50 66
ATENOLOL 50 43 50 7
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 19, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.